[Theoretical and clinical aspects of the antacid therapy].
D000471:Alkalosis / Q000139:chemically induced; D000863:Antacids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002119:Calcium Carbonate / Q000494:pharmacology; D002254:Carbonates / Q000494:pharmacology; D004347:Drug Interactions; D005750:Gastric Juice / Q000187:drug effects*; D005755:Gastrins / Q000097:blood / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced; D008277:Magnesium Oxide / Q000009:adverse effects / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010437:Peptic Ulcer / Q000188:drug therapy; D012964:Sodium / Q000494:pharmacology; D013272:Stomach Diseases / Q000188:drug therapy*
D000863:Antacids; D002254:Carbonates; D005755:Gastrins; D010276:Parasympatholytics; D008277:Magnesium Oxide; D012964:Sodium; D010434:Pepsin A; D002119:Calcium Carbonate
Theoretische und klinische aspekte der antacidatherapie